Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACRE: Short-Course Radiotherapy vs Radiochemotherapy in Elderly Rectal Cancer
NCT02551237Phase 3Completed
- Sponsor
- Unicancer
- Start
- Jan 2016
- Primary completion
- Aug 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in Rectal cancer (RC), sponsored by Unicancer. Started Jan 2016; status: completed.
02
Drugs
capecitabine
03
Conditions
Rectal cancer (RC)
Beyond the preview
Go deeper on NCT02551237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551237.